Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.

Greg Moeck, Leanne B Gasink + Show 7 more

https://doi.org/10.1128/aac.00236-24

Copy DOI

Journal: Antimicrobial agents and chemotherapy	Publication Date: May 23, 2024
License type: CC BY 4.0

Abstract

This study is registered with ClinicalTrials.gov as NCT03840148.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author